Acute Coronary Syndrome Part 2 Flashcards

1
Q

What different life factors give points in the TIMI risk scores?

A
  • over 65 y/o
  • more than 3 risk factors for CAD
  • prior coronary stenosis
  • > 50% ST deviation on an ECG
  • more than 2 anginal events in prior 24 hours
  • use of aspirin in prior 7 days
  • elevated cardiac biomarkers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some other high risk factors for ACS?

A
  • hemodynamic instability
  • refractory angina
  • recurrent angina or ischemia at rest
  • signs and symptoms of HF
  • sustained VT
  • ECG changes (new ST depression)
  • prior PCI/CABG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What patients are generally referred for a CABG?

A
  • high risk patients with multi-vessel disease may be referred for a CABG (hold DAPT 5-7 days prior to surgery if possible)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When is an angiography/PCI revascularization indicated in patients?

A

for high risk patients with a TIMI risk score of >2, or in the presence of other high risk characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

UN/STEMI patients who underwent early invasive strategy with PCI should receive what?

A
  • DAPT (as would a STEMI patient receive)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How long should DAPT therapy be recommended in all ACS patients?

A
  • recommend DAPT therapy for 1 year in all ACS patients

over 1 year therapy is controversial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How long should DAPT therapy be recommended in all ACS patients?

A
  • recommend DAPT therapy for 1 year in all ACS patients

over 1 year therapy is controversial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If a patient is at very high risk of having another infarction, what should be used: clopridogrel or ticagrelor?

A
  • ticagrelor

there is a reduction in endpoint death from CV causes, nonfatal MI or stroke in the ticagrelor group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are GP IIb/IIIa inhibitors?

A

they are potent anti-platelet agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the action of GP IIb/IIIa agents?

A
  • they block the binding of fibrinogen to GP IIb/IIIa receptors on the platelet surface, therefore inhibiting platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are examples of the GP IIIb/IIIa receptor antagonists?

A
  • abciximab, epifibatide, tirofiban
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When do GP IIb/IIIa inhibitors have benefit?

A
  • they have demonstrated benefit in reducing death/MI in patients who have undergone PCI (early invasive strategy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What anticoagulant is the standard to give?

A
  • LMWH is the standard to give in patients (long acting and has renal elimination however- disadvantage)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What needs to be monitored in patients receiving anticoagulant therapy?

A
  • need to monitor signs of bleeding, Hbg and platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the action of fondaparinux?

A
  • indirect acting factor Xa inhibitor

- we do not usually give this unless the person is at a very high risk of bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the goal of adding adjunct therapy to anticoagulants?

A
  • reduce the risk short term and long term complications associated with ACS
  • slow the progression of coronary heart disease and minimize the risk of future cardiovascular events and other morbidities
  • improve mortality and quality of life
17
Q

What medications generally have to be used for life after an MI?

A
  • ASA, ticagrelor/clopridogrel and ACE inhibitors are all for life
18
Q

How long do beta blockers need to be taken after an event?

A
  • for 3-4 years
19
Q

What 4 medications should be started before a person leaves the hospital for long term risk reduction?

A
  • ASA, beta blockers, statins, ACEI (all 4 provide a cumulative risk reduction of 75%)
20
Q

What is the role of omega-3 fatty acids in risk reduction?

A
  • unclear if omega 3 fats alter the total mortality, combined cardiovascular events or cancers in people with, or at high risk of, cardiovascular disease or in the general population
21
Q

What vitamins/supplements are NOT recommended in preventing heart disease

A
  • vitamins A,C,E and beta caroteine

- folic acid either alone or in combination with vitamin B6 or vitamin B12

22
Q

Hormone therapy is not recommended in post menopausal women post MI because of what?

A
  • they may increase CV risk
23
Q

What else should be avoided post MI?

A
  • NSAIDs, including selective COX2 inhibitors should be avoided if possible
24
Q

What medication should be avoided in those that are active, ongoing users of cocaine or methamphetamine?

A
  • beta blockers (should be avoided due to the risk of potentiating coronary spasm)